top of page

Perjeta and Herceptin

By Jasmine Shukla

Last updated 4/1/2021


Breast Cancer is the second most common form of cancer (in women), after skin cancer, and affects 1 in 8 women. Breast cancer impacts a patient's physical, mental, and emotional well being while also affecting those who are caring for them. Women suffering or recovering from breast cancer often find it difficult to lead a normal life and struggle to revert back to their life before they were diagnosed with this life-threatening disease. This struggle stems from the severe and excruciating treatments that often accompany breast cancer, even when patients know that these treatments are mandatory for survival.



In the past few years, however, the pattern of treatment and chances of recovery have been bolstered significantly due to the innovations of several useful drugs, medications and therapies. Perjeta, Herceptin, and at times, a combination of both can be successfully applied - treatments for those diagnosed with breast cancer.


Perjeta Background

Perjeta (Pertuzumab) is a prescription medicine approved for use in combination with Herceptin and chemotherapy for use prior to surgery in patients with HER2-positive, or early stage breast cancer. Perjeta can also be prescribed for use after surgery has taken place in order to prevent the recurrence of HER2-positive breast cancer - as the risk is quite high during this period. The specifications of both these drugs mainly focuses on stopping the growth of cancer cells right from the beginning.


Herceptin Background

Herceptin (Trastuzumab), is an application used as a medication against HER2-positive breast cancer both during the early and/or advanced/metastatic stage for stopping the growth of cancer. It has been approved by the US Food and Drug Department. Herceptin, in the early stages, can be employed as a regimen (prescribed course medical treatment) portion along with chemotherapy regimen which contains an anthracycline for lessening the risk of breast cancer recurring.


The Path to Perjeta

The drugs mentioned here are monoclonal antibodies, i.e they bind to specific cells or tissues within the body and function as immunotherapy for the patients. Herceptin was introduced about 15 years ago in order to target HER2 as a clinical treatment for patients with breast cancer. However, Herceptin alone was not proving to be sufficient enough to fight against it as most patients with HER2-positive metastatic breast cancer displayed a progression in their disease rather than an improvement. This result indicated that new therapies were needed which, as a consequence, lead to the invention of Perjeta.


Perjeta and Herceptin Combination

Perjeta, together with Herceptin, plus Docetaxel (a chemotherapy medication applicable for treating a number of cancers like breast, skin, neck, etc.) has become a benchmark for HER2 positive metastatic breast cancer patients. Perjeta, when administered with Herceptin provides synergistic activity as per clinical and preclinical data.


Perjeta and Herceptin Dose:

Perjeta and Herceptin are administered every 3 weeks in the following amounts of doses:


2 ways of giving doses of both of these drugs to the patients-


1. Loading Dose, an initial higher dose given at the start of any particular treatment course before dropping down to lower regular dose, also helpful to drugs that requires elimination from the body at a slower rate.

For Perjeta, Loading dose: 840mg with an infusion time of 60 minutes (volume with respect to flow rate).


For Herceptin, Loading dose: 8mg/kg with an infusion time of 90 minutes

Chemotherapy varies as per the regimen.


2. Subsequent Doses, the normal/regular once taken periodically.

For Perjeta, Subsequent dose: 420mg with an infusion time of 30-60 minutes

For Herceptin, Subsequent dose: 6mg/kg with an infusion time of 30-90 minutes

Chemotherapy varies as per the regimen.

Herceptin is a 1 year treatment, taken every three weeks, resulting in about 17 or 18 infusions. Side effects are pretty well tolerated, though you may experience fatigue, loss of appetite, nausea, headaches, runny nose, sore throat.


Perjeta and Herceptin Cost:

Prices of these drugs' doses are around $7.93/mg and $6.43/mg for Perjeta and Herceptin respectively. As observed these treatments normally have significant expenses that are unaffordable to most patients falling under low income groups. However, there are certain insurance plans available that help cover these expenses to some rate. It is usually advised to talk your respected doctor regarding the cost and expenses and coverage of insurance properly and satisfactorily. In addition, both of these drugs also have certain side effects (which are elaborated on in another blog (Side Effects of Perjeta), and therefore must be taken under medical observation and after proper consultations.

182 views0 comments

Recent Posts

See All

Meditation Mondays:

Chakra Chanting with Gloria

Mondays at 10:00 a.m. ET 

RSVP

Thursday Night Thrivers:

All Stages

Thursdays at 7:00 p.m. ET

RSVP

 

Thursday Night Thrivers:

Metastatic Breast Cancer

First and third Thursdays

of the month at 7:00 p.m. ET

RSVP

 

Thursday Night Thrivers:

Inflammatory Breast Cancer

Second Thursday

of the month at 7:00 p.m. ET

RSVP

Tuesday Night Thrivers

Después de un Diagnóstico:

Spanish support group

2do y Cuarto Martes de cada mes 

7:00 p.m. ET

RSVP

Art Therapy

October 2 6:00 p.m. ET

RSVP

Yoga Stretching for DIEP flap

October 3 6:00 p.m. ET

RSVP

Yoga with

Chair assist 

October 10, 11:30 a.m. ET

RSVP

Writing Workshop:

Reflect and Recharge

October 16, 6:00 p.m. ET

RSVP

Restorative Yoga:

Fall into Meditation

October 17  6:40 p.m. ET

RSVP

Qi Gong 

October 24, 11:30 a.m. ET

RSVP

Breast Cancer Book Club

November 5, 11:00 a.m. ET

RSVP

Más eventos en español

RSVP

Upcoming Events

1

Surviving Breast Cancer provides breast cancer support, events, and webinars at no cost to you! Whether you are looking to gain more knowledge on a particular topic or meet up with other breast cancer survivors, we have something for everyone. 

2

Our standing appointment on Thursdays is for all stages. We also host specific breakout groups once a month for specific stages and subtypes such as Metastatic breast cancer, and Inflammatory Breast Cancer, etc. 

3

The Book Club meets the first Sunday of every month at 11 am ET. You are welcome to join each month or pick and choose your month based on your availability and the book we are reading. 

4

Through art, writing, and other creative modalities, we hold the power to manage our stress, make sense of our now, and relax into moments of stillness. 

5

Free, monthly, online classes in restorative yoga, yoga for breast cancer, and Zumba. 

6

Después de un Diagnóstico

bottom of page